Immunic Therapeutics

Events and Presentations

Events and Presentations

DMDG 50th Open Meeting 2024
 Monday, September 2, 2024 -
Wednesday, September 4, 2024
Venue
  York, United Kingdom
 

Juliano R. Fonseca, Ph.D., Head of Preclinical Development at Immunic, will present data from Immunic’s phase 1, open-label mass balance and pharmacokinetics study of vidofludimus calcium in a poster presentation.

  • Title: Mass Balance and ADME Properties of [14C]-IMU-838 Following Oral Administration to Healthy Male Subjects
  • Poster Number: 31
  • The poster will be available to view the entire length of the meeting.